Antibodies for malondialdehyde low density lipoproteins and oxidised low density lipoproteins for detection of arterial diseases such as atherosclerosis

摘要

Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidised low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.